Using random regression model analysis in longitudinal clinical trial of pramipexole in early Parkinson's disease

被引：0
|
作者：
Lai, PY [1 ]
Corrigan, MH [1 ]
Denahan, AQ [1 ]
机构：
[1] PHARMACIA & UPJOHN INC,KALAMAZOO,MI 49001
来源：
PSYCHOPHARMACOLOGY BULLETIN | 1997年 / 33卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：544 / 544
页数：1
相关论文
共 50 条
  • [21] Clinical pharmacokinetics of pramipexole, ropinirole and rotigotine in patients with Parkinson's disease
    Contin, Manuela
    Lopane, Giovanna
    Mohamed, Susan
    Calandra-Buonaura, Giovanna
    Capellari, Sabina
    De Massis, Patrizia
    Nassetti, Stefania
    Perrone, Alessandro
    Riva, Roberto
    Sambati, Luisa
    Scaglione, Cesa
    Cortelli, Pietro
    PARKINSONISM & RELATED DISORDERS, 2019, 61 : 111 - 117
  • [22] Pramipexole v. levodopa as initial treatment for Parkinson's disease: A randomized clinical-economic trial
    Noyes, K
    Dick, AW
    Holloway, RG
    MEDICAL DECISION MAKING, 2004, 24 (05) : 472 - 485
  • [23] Effects of piribedil and pramipexole in tremor predominant patients with early Parkinson's disease
    Subutay-Oztekin, N.
    Oztekin, M. F.
    Sari-Polat, R.
    Ak, F.
    MOVEMENT DISORDERS, 2008, 23 (01) : S311 - S311
  • [24] Performance Evaluation of Random Forest Regression Model in Tracking Parkinson's Disease Progress
    Peterek, Tomas
    Dohnalek, Pavel
    Gajdos, Petr
    Smondrk, Maros
    2013 13TH INTERNATIONAL CONFERENCE ON HYBRID INTELLIGENT SYSTEMS (HIS), 2013, : 83 - 87
  • [25] The effectiveness of pramipexole in early and advanced Parkinson's disease and comparison of the results with ropinirole
    Karakaya, F.
    Ozturk, S.
    Ceviz, I.
    Kusbeci, O. Yilmaz
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 668 - 668
  • [26] Pramipexole - A review of its use in the management of early and advanced Parkinson's disease
    Dooley, M
    Markham, A
    DRUGS & AGING, 1998, 12 (06) : 495 - 514
  • [27] Pramipexole and levodopa in early Parkinson's disease - Dynamic changes in cost effectiveness
    Noyes, K
    Dick, AW
    Holloway, RG
    PHARMACOECONOMICS, 2005, 23 (12) : 1257 - 1270
  • [28] Long-term safety and efficacy of pramipexole in early Parkinson's disease
    Bressman, SB
    Shulman, LM
    Tanner, CM
    Rajput, AH
    Shannon, KM
    Wright, E
    NEUROLOGY, 1999, 52 (06) : A261 - A261
  • [29] Analysis of pramipexole dose-response relationships in Parkinson's disease
    Wang, Ying
    Sun, Sheng-Gang
    Zhu, Sui-Qiang
    Liu, Chun-Feng
    Liu, Yi-Ming
    Di, Qing
    Shang, Hui-Fang
    Ren, Yan
    Xiang, Wei
    Chen, Sheng-Di
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 83 - 89
  • [30] Analysis of longitudinal data in an Alzheimer's disease clinical trial
    Thomas, RG
    Berg, JD
    Sano, M
    Thal, L
    STATISTICS IN MEDICINE, 2000, 19 (11-12) : 1433 - 1440
12345